A patient in New Zealand became the first person to receive a gene-editing serum to permanently lower levels of ‘bad’ LDL cholesterol, a major cause of heart disease worldwide. The procedure involved injecting an improved version of the gene-editing tool, CRISPR, to turn off a ‘bad’ gene by replacing a single letter in the liver DNA.
Let’s connect.
Do you have any questions about our projects or our site in general? Do you have any comments or ideas you would like to share? Please feel free to call us, email us or simply send us a message from here.
Copyright © 2025 The HEAD Foundations. All Rights Reserved.
